Lv1
30 积分 2025-06-24 加入
IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy
3天前
已完结
Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial
15天前
已完结
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial final results
15天前
已完结
Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure
3个月前
已完结
Single-day nonactivated IL-18-armed CAR T cells establish a durable, stemlike state with enhanced persistence
3个月前
已完结
Ways of improving precise knock-in by genome-editing technologies
4个月前
已完结
In vivo site-specific engineering to reprogram T cells
5个月前
已完结
Basic enables selection-free efficient knockin of large DNA in primary human T cells
5个月前
已关闭
Sensitive CAR T cells redefine targetable CD70 expression in solid tumors
5个月前
已完结
Transduction of Quiescent Human Hematopoietic Stem and Progenitor Cells Using Lentiviral Vectors and Virus‐Like Particles
6个月前
已完结
皖公网安备34019202002308
